SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-14-002567
Filing Date
2014-08-06
Accepted
2014-08-06 09:46:18
Documents
16
Period of Report
2014-08-06

Document Format Files

Seq Description Document Type Size
1 6-K zk1415372.htm 6-K 17729
2 EXHIBIT 1 exhibit_1.htm EX-99 64099
3 exhibit_11.jpg GRAPHIC 41034
4 exhibit_12.jpg GRAPHIC 27063
5 exhibit_13.jpg GRAPHIC 71103
6 exhibit_14.jpg GRAPHIC 23991
7 exhibit_15.jpg GRAPHIC 60932
8 exhibit_16.jpg GRAPHIC 49434
9 exhibit_17.jpg GRAPHIC 49434
10 exhibit_18.jpg GRAPHIC 77416
11 exhibit_19.jpg GRAPHIC 23414
12 exhibit_110.jpg GRAPHIC 20039
13 exhibit_111.jpg GRAPHIC 20039
14 exhibit_112.jpg GRAPHIC 20039
15 exhibit_113.jpg GRAPHIC 81642
16 exhibit_114.jpg GRAPHIC 62782
  Complete submission text file 0001178913-14-002567.txt   950412
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 141018350
SIC: 2834 Pharmaceutical Preparations